Magnus Nylén
Direttore/Membro del Consiglio presso SELECTIMMUNE PHARMA AB (PUBL)
Profilo
Magnus Nylén is currently a Director at Hamlet BioPharma AB, a Director at SelectImmune Pharma AB since 2022, and the Owner of Partner Fondkommission AB since 2013.
He completed his undergraduate degree at Boston University.
Posizioni attive di Magnus Nylén
| Società | Posizione | Inizio |
|---|---|---|
| SELECTIMMUNE PHARMA AB (PUBL) | Direttore/Membro del Consiglio | 23/11/2022 |
| HAMLET PHARMA AB (PUBL) | Direttore/Membro del Consiglio | - |
Partner Fondkommission AB
 Partner Fondkommission AB Investment ManagersFinance Partner Fondkommission AB provides financial advisory services. It offers mergers and acquisitions, brokerage, and issuer services. The company was founded in 2007 and is headquartered in Gothenburg, Sweden. | Corporate Officer/Principal | 01/01/2013 |
Formazione di Magnus Nylén
| Boston University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| SELECTIMMUNE PHARMA AB (PUBL) | Health Technology |
| HAMLET PHARMA AB (PUBL) | Health Technology |
| Aziende private | 1 |
|---|---|
Partner Fondkommission AB
Partner Fondkommission AB Investment ManagersFinance Partner Fondkommission AB provides financial advisory services. It offers mergers and acquisitions, brokerage, and issuer services. The company was founded in 2007 and is headquartered in Gothenburg, Sweden. | Finance |
- Borsa valori
- Insiders
- Magnus Nylén
